BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 317640)

  • 1. The peripheral T and B lymphocytes in uremic patients.
    Sobczyk J
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):681-6. PubMed ID: 317640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic reactivity in uremic patients in hemodialysis].
    Rotolo U
    Recenti Prog Med; 1979 Feb; 66(2):116-23. PubMed ID: 312517
    [No Abstract]   [Full Text] [Related]  

  • 3. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

  • 4. T and B lymphocytes in patients with hay fever.
    Małolepszy J; Kraus-Filarska M; Panaszek B; Liebhart E; Szeliga W; Litwa M
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):589-92. PubMed ID: 6970026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations.
    Ponzetto A; Arrigoni A
    G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T and B lymphocytes in patients with steroid-dependent bronchial asthma during long-term treatment.
    Rogala E; Szymaniec J; Szymik N; Huzarski J; Holak H
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):663-8. PubMed ID: 317639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.
    Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Paulitou A; Sakellariou G
    Ren Fail; 2005; 27(3):279-82. PubMed ID: 15957543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular immunity in dialysis patients using the lymphocyte transformation test (LTT) in comparison to conservatively treated patients with chronic terminal renal failure].
    Meissner S; Schwenke H; Witzel E; Achenbach H
    Z Urol Nephrol; 1986 Apr; 79(5):277-86. PubMed ID: 3526744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune dysfunction in uremia.
    Cohen G; Haag-Weber M; Hörl WH
    Kidney Int Suppl; 1997 Nov; 62():S79-82. PubMed ID: 9350688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T mediated immunity in patients undergoing periodic hemodialysis.
    Piazza I; Alibrandi F; Semenzato G; Battistella L; Amadori G; Gasparotto G
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):631-6. PubMed ID: 314813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
    Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G
    Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [State of T- and B-immunity in heart decompensation].
    Baranovskiĭ PV
    Vrach Delo; 1983 Feb; (2):42-4. PubMed ID: 6601882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of the dinitrochlorobenzene test in evaluation of cellular immunity in uremic patients].
    Giacchino F; Triolo G; Coppo R; Alloatti S; Quarello F; Rotunno M; Martini PF; Segoloni G; Piccoli G; Vercellone A
    Minerva Nefrol; 1979; 26(3):343-8. PubMed ID: 318059
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase of peripheral B lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
    Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T- and B-lymphocyte changes in lymphogranulomatosis].
    Il'in NV; Vinokurova NA; Gershanovich ML; Letskiĭ VB
    Vopr Onkol; 1979; 25(6):19-22. PubMed ID: 380155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphocyte count in the blood of stomach cancer patients].
    Volodarskiĭ VL; Maslova MG; Gurina LI; Dybova TV
    Vestn Khir Im I I Grek; 1981 Feb; 126(2):23-7. PubMed ID: 6972117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T and B cells in borderline (BB) leprosy.
    Biggins T; Narayanan RB; Ramu G; Desikan KV
    Indian J Lepr; 1988 Jan; 60(1):21-5. PubMed ID: 3264563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Method for the characterization of peripheral lymphocytes in humans and their significance].
    Magrì D; Spadacenta F; Tritto MC
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):102-7. PubMed ID: 6969080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative evaluation of T and B lymphocytes in the peripheral blood of patients with psoriasis].
    Sztaba-Kania M; Placek W
    Przegl Dermatol; 1985; 72(6):512-6. PubMed ID: 3879540
    [No Abstract]   [Full Text] [Related]  

  • 20. Status of T and B lymphocytes in peripheral blood.
    Singh PK; Ratna ; Jain PK; Mital VP
    Lepr India; 1983 Jul; 55(3):560-5. PubMed ID: 6606733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.